Revista de la Sociedad Argentina de Diabetes
LIPOTOXICIDAD EN MÚSCULO ESQUELÉTICO, UN CAMINO PARA INVESTIGAR
Resumen
Palabras clave
Texto completo:
PDFReferencias
Cusi K. The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr Diab Rep 2010; 10:306-315.
Ferrara D, Montecucco F, Dallegri F, Carbone F. Impact of different ectopic fat depots on cardiovascular and meta¬bolic diseases. J Cell Physiol 2019; 1-12.
Consitt LA, Bell JA, Houmard JA. Intramuscular lipid metabolism, insulin action, and obesity. IUBMB. Life 2009; 61, 47-55.
Randle P, Garland P, Newsholme EA, Hales C. The glu¬cose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-789.
Metcalfe LK, Smith GC, Turner N. Defining lipid media¬tors of insulin resistance. Controversies and challenges. J Mol Endocrinol 2018; 62, R65-R82.
Miksztowicz V, Schreier L, McCoy M, Lucero D, Fassio E, Billheimer J, Rader DJ, Berg G. Role of SN1 lipases on plasma lipids in metabolic syndrome and obesity. Arte¬rioscler Thromb Vasc Biol 2014 Mar; 34(3):669-75.
Barchuk M, Miksztowicz V, Zago V, Cevey A, López G, Goren N, Friedman S, Gelpi RJ, Morales C, Fernandez Tomé MDC, Schreier L, Berg G. Endothelial lipase is an alternative pathway for fatty acid release from lipopro¬teins: evidence from a high fat diet model of obesity in Rats. Lipids 2018 Oct; 53(10):993-1003.
Kiens B. Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev 2006; 86(1): 205-43.
Bandet CL, Tan-Chen S, Bourron O, Le Stunff H, Hajduch E. Sphingolipid metabolism: new insight into ceramide-induced lipotoxicity in muscle cells. Int J Mol Sci 2019 Jan 23; 20(3).
DOI: http://dx.doi.org/10.47196/diab.v53i2.146
Copyright (c) 2019 Sociedad Argentina de Diabetes Asociación Civil
